Jacobio Pharmaceuticals Group Co., Ltd.
Status: Publicly traded
Direct answer
Jacobio Pharmaceuticals Group Co., Ltd. is publicly traded on HKSE under the ticker 1167.HK.
Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm specializing in the proprietary discovery and development of oncology therapies. Its primary drug development initiatives feature two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors, JAB-3312 and JAB-3068, which are being investigated for esophageal cancer. Also in development is...
Can you invest in Jacobio Pharmaceuticals Group Co., Ltd.?
Yes. Jacobio Pharmaceuticals Group Co., Ltd. is publicly traded on HKSE under the ticker 1167.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jacobio Pharmaceuticals Group Co., Ltd.
Detailed equity research is provided by MarketSnap.